Get my own profile
Public access
View all14 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Alfred ZippeliusProfessor of Translational Oncology, Co-Head Medical OncologyVerified email at usb.ch
- Heinz LäubliAssistant Professor for Cellular Cancer Immunotherapy, and Senior Attending Physician, OncologyVerified email at unibas.ch
- Daniela Stefanie ThommenDivision of Molecular Oncology and Immunology, The Netherlands Cancer InstituteVerified email at nki.nl
- Sarah DimeloeUniversity of BirminghamVerified email at bham.ac.uk
- Christian KleinRoche Pharma Research and Early Development, Roche Innovation Center ZurichVerified email at roche.com
- Ton N.M. SchumacherThe Netherlands Cancer Institute, Third Rock VenturesVerified email at nki.nl
- Andreas RollerRoche Pharma Research and Early Development (pRED)Verified email at roche.com
- Viktor KoelzerInstitute of Medical Genetics and Pathology, University Hospital BaselVerified email at usb.ch
- Christopher AmosDirector of Clinical and Translational Research, Baylor College of MedicineVerified email at bcm.edu
- Ajit VarkiUCSDVerified email at ucsd.edu
- Viola HeinzelmannProfessor of Gynecology and Obstetrics, University of BaselVerified email at usb.ch